Moderna
MRNA
#281
Rank
$50.12 B
Marketcap
$123.64
Share price
-0.55%
Change (1 day)
-71.26%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: $50.12 Billion

As of September 2022 Moderna has a market cap of $50.12 Billion. This makes Moderna the world's 281th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2022

End of year Market Cap

Year Market cap Change
2022$50.12 B-51.32%
2021$102.97 B149.1%
2020$41.33 B528.01%
2019$6.58 B31.11%
2018$5.02 B

End of Day market cap according to different sources

On Sep 24th, 2022 the market cap of Moderna was reported to be:

$48.36 Billion
by Yahoo Finance
$48.36 Billion
by CompaniesMarketCap
$48.36 Billion
by Nasdaq
$49.17 Billion
by Iex Cloud

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
$438.33 B 774.40%๐Ÿ‡บ๐Ÿ‡ธ USA
$166.30 B 231.75%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$219.83 B 338.54%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.25 B-99.50%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.97 B-94.06%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.38 B-99.24%๐Ÿ‡บ๐Ÿ‡ธ USA
$24.01 B-52.10%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.23 B-93.55%๐Ÿ‡บ๐Ÿ‡ธ USA